Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT00678210 · COMPLETED
Trial details
- NCT number
- NCT00678210
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2009-08-01
- Enrollment
- 197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.